Michael Midmer Email

CEO . Zucara

Current Roles

Employees:
15
Revenue:
$2.3M
About
Zucara Therapeutics, a CDRD and MaRS Innovation portfolio company, is developing the first drug therapy to prevent hypoglycemia in people with diabetes. Our first-in-class therapeutic is focused on improving glucagon counterregulation by inhibiting somatostatin which is dysregulated in Type 1 diabetes. Preventing hypoglycemia will dramatically change diabetes disease management, improving both patient health and quality of life..
Zucara Address
2405 Wesbrook Mall
Vancouver, BC
CAN
Zucara Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.